Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Parallel-group Randomized Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

NCT01850446 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT01850446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Parallel-group Randomized Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
February 20, 2015
Completion date
April 16, 2018
Enrollment
184 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

influenza